510(k) Report

510(k) · Cleared

Cleared

Medstone, Uropro 2000, Tomographic Option

K013620510(k) TraditionalCleared Jan 22, 200278-day reviewClass II21 CFR 892.1740

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medstone Intl., Inc. · IZF System, X-Ray, Tomographic

Cleared on Jan 22, 2002 after a 78-day review. The FDA summary names its predicate without a number.

Decided
Jan 22, 2002
Review
78 days
Class
Class II
Product code
IZF
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K013620Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IZF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IZF device

  1. #1 K250850 Nanox.ARC Xscore 15.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Pausch Corporation Microtom, Tomographic Option
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All IZF devices

IZF System, X-Ray, Tomographic: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · IZF

2in 2025

2012: 12013: 12019: 12020: 12021: 12023: 22024: 12025: 22026 (partial year): 1
2007high 2 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IZF

Too few IZF 510(k)s in any year since 2007 to give a median.

Recalls per year · IZF

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IZF

1in 2021

2007: 12008: 12010: 62011: 242012: 32013: 12014: 12015: 12019: 12021: 1
2007high 24 (2011) · low 0 (2009)2025

MAUDE reports naming product code IZF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—01
20090—00
20100—06
20110—024
20121—03
20131—01
20140—01
20150—01
20160—00
20170—00
20180—00
20191—01
20201—00
20211—01
20220—00
20232—00
20241—00
20252—10
20261—0—

What is it indicated for?

The Medstone, Radiographic Linear Tomography Option is designed as an optional additional device to the Medstone UroPro 2000 table, intended for use in general radiology. It is designed to enable the production of diagnostic radiologic images of a specific linear cross- sectional plane of the body, eliminating unwanted anatomy and detail by motion blurring of other planes. This device is designed to provide and control the sweep speed and angle of a…

Read the full statement (113 words)

The Medstone, Radiographic Linear Tomography Option is designed as an optional additional

device to the Medstone UroPro 2000 table, intended for use in general radiology. It is

designed to enable the production of diagnostic radiologic images of a specific linear cross-

sectional plane of the body, eliminating unwanted anatomy and detail by motion blurring of

other planes.

This device is designed to provide and control the sweep speed and angle of a tomography

function to enable the production of a properly imaged X-ray film to accomplish diagnostic

imaging of a patient.

The table and tomography option are intended to be used by trained professionals, schooled

in proper radiology procedures, techniques, positioning and safety.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K013620: Medstone, Uropro 2000, Tomographic Option.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K013620

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Page last updated Nov 3, 2026